Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06289062
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-19
Brief Title:
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Organization Data
Organization:
Tongji Hospital
Class:
OTHER
Study ID:
NACI-CERV-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tongji Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Kezhen Li
Responsible Party Title:
Prof
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Tongji Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Anhui Provincial Cancer Hospital | OTHER |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | OTHER |
| Women Hospital School of Medicine Zhejiang University | UNKNOWN |
| Third Military Medical University | OTHER |
| Beijing Friendship Hospital | OTHER |
| Sichuan Cancer Hospital and Research Institute | OTHER |
| Tianjin Medical University | OTHER |
| West China Second University Hospital | OTHER |
| Xiangya Hospital of Central South University | OTHER |
| Qilu Hospital of Shandong University | OTHER |
| Gansu Cancer Hospital | OTHER |
| Zhejiang Cancer Hospital | OTHER |
| Shengjing Hospital | OTHER |